ZhuZhou QianJin Pharmaceutical Co.,Ltd

SHSE:600479 Stock Report

Market Cap: CN¥5.4b

ZhuZhou QianJin PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

ZhuZhou QianJin PharmaceuticalLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥46.8M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.5B and CN¥1.4B respectively. ZhuZhou QianJin PharmaceuticalLtd's EBIT is CN¥363.4M making its interest coverage ratio -9.4. It has cash and short-term investments of CN¥1.7B.

Key information

1.5%

Debt to equity ratio

CN¥46.83m

Debt

Interest coverage ratio-9.4x
CashCN¥1.73b
EquityCN¥3.06b
Total liabilitiesCN¥1.39b
Total assetsCN¥4.45b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 600479's short term assets (CN¥3.3B) exceed its short term liabilities (CN¥1.3B).

Long Term Liabilities: 600479's short term assets (CN¥3.3B) exceed its long term liabilities (CN¥94.2M).


Debt to Equity History and Analysis

Debt Level: 600479 has more cash than its total debt.

Reducing Debt: 600479's debt to equity ratio has increased from 0.9% to 1.5% over the past 5 years.

Debt Coverage: 600479's debt is well covered by operating cash flow (893%).

Interest Coverage: 600479 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies